Evidence-based assessment of the impact of the WHI on women's health

References

• Rossouw JE, Anderson GL, Prentice RL, . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the WHI randomized controlled trial. JAMA 2004;291:1701–12
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Prentice RL, Manson JE, . Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465–77. Erratum in JAMA 2008;299:1426
   PubMed Web of Science ®Google Scholar
• MacLennan AH, Sturdee D. The end of WISDOM. Climacteric 2002;5:313–16
   PubMed Web of Science ®Google Scholar
• Harman SM, Brinton EA, Cedars M, . KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005;8:3–12
   PubMed Web of Science ®Google Scholar
• Hodis HN for the ELITE study group. http://clinicaltrials.gov/ct2/show/NCT00114517
   Google Scholar
• Sturdee DW, Pines A, On behalf of the International Menopause Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventative strategies for midlife health. Climacteric 2011;14:302–20
   PubMed Web of Science ®Google Scholar
• Buist DS, Newton KM, Miglioretti DL, . Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004;104:1042–50
   PubMed Web of Science ®Google Scholar
• Helenius IM, Korenstein D, Halm EA. Changing use of hormone therapy among minority women since the Women's Health Initiative. Menopause 2007;14:216–22
   PubMed Web of Science ®Google Scholar
• Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140:184–8
   PubMed Web of Science ®Google Scholar
• Ness J, Aronow WS, Newkirk E, McDanel D. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial. J Gerontol A Biol Sci Med Sci 2005;60:460–2
   PubMed Web of Science ®Google Scholar
• Menon U, Burnell M, Sharma A, . Decline in use of hormone therapy among postmenopausal women in the United Kingdom. Menopause 2007;14:462–7
   PubMed Web of Science ®Google Scholar
• Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiol Drug Saf 2007;16:17–27
   PubMed Web of Science ®Google Scholar
• Chaikittisilpa S, Jirapinyo M, Chaovisitsaree S, . Impact of Women's Health Initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics. J Med Assoc Thai 2007;90:628–35
   PubMedGoogle Scholar
• Heitmann C, Greiser E, Dören M. The impact of the Women's Health Initiative randomized controlled trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany. Menopause 2005;12:405–11
   PubMed Web of Science ®Google Scholar
• Silverman BG, Kokia ES. Use of hormone replacement therapy, 1998–2007: sustained impact of the Women's Health Initiative findings. Ann Pharmacother 2009;43:251–8
   PubMed Web of Science ®Google Scholar
• Leung KY, Ling M, Tang GW. Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial. Maturitas 2005;52:277–85
   PubMed Web of Science ®Google Scholar
• Maclennan AH, Gill TK, Broadbent JL, Taylor AW. Continuing decline in hormone therapy use: population trends over 17 years. Climacteric 2009;12:122–30
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S. Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas 2007;56:420–8
   PubMed Web of Science ®Google Scholar
• Leon-Leon P, Chedraui P, Hidalgo L, . Hormone therapy for the management of the menopause in Ecuador: perception, use and knowledge among middle-aged women. Gynecol Endocrinol 2008;24:580–5
   PubMed Web of Science ®Google Scholar
• Blümel JE, Castelo-Branco C, Riquelme R, . Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause 2002;9:377–80
   PubMed Web of Science ®Google Scholar
• Blümel JE, Castelo-Branco C, Kerrigan N, . Influences of hormone replacement therapy on postmenopausal women's health perceptions. Menopause 2003;10:235–40
   PubMed Web of Science ®Google Scholar
• Coo H, O'Connor KS, Hunter D. Women's knowledge of hormone therapy. Patient Educ Couns 2001;45:295–301
   PubMed Web of Science ®Google Scholar
• Breslau ES, Davis WW, Doner L, . The hormone therapy dilemma: women respond. J Am Med Womens Assoc 2003;58: 33–43
   PubMedGoogle Scholar
• Pan HA, Wu MH, Hsu CC, Yao BL, Huang KE. The perception of menopause among women in Taiwan. Maturitas 2002;41: 269–74
   PubMed Web of Science ®Google Scholar
• Rolnick SJ, Kopher RA, Defor TA, Kelley ME. Hormone use and patient concerns after the findings of the Women's Health Initiative. Menopause 2005;12:399–404
   PubMed Web of Science ®Google Scholar
• Huang K-E, Xu L, Masari IN, . The Asian Menopause Survey: knowledge, perception. Hormone treatment and sexual function. Maturitas 2010;65:276–83
   PubMed Web of Science ®Google Scholar
• MacLennan AH. Death by ‘natural’ causes! Placebos, poisons and potions. In Genazzani AR, ed. Menopause State of the Art: Proceedings of the 13th Congress on Menopause 2011. CIC Edizioni Internationali, 2011:118
   Google Scholar
• MacLennan AH. Evidence-based review of therapies at the menopause. Int J Evid Based Health 2009;7:112–23
   PubMedGoogle Scholar
• Islam S, Liu Q, Chines A, Helzner E. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000–2005. Menopause 2009;16:77–83
   PubMed Web of Science ®Google Scholar
• Karim R, Dell RM, Greene DF, . Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause 2011;18:1172–7
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Ciaponi M, Genazzani AR. The HRT misuse and osteoporosis epidemic: a possible future scenario. Climacteric 2007;10:273–5
   PubMed Web of Science ®Google Scholar
• Shetty KD, Vogt WB, Bhattacharya J. Hormone replacement therapy and cardiovascular health in the United States. Med Care 2009;47:600–6
   PubMed Web of Science ®Google Scholar
• Martin RM, Wheeler BW, Metcalfe C, Gunnell D. What was the immediate impact on population health of the recent fall in hormone replacement therapy prescribing in England? Ecological study. J Public Health (Oxf) 2010;32:555–64
   PubMed Web of Science ®Google Scholar
• Clarke CA, Glaser SL, Uratsu CS, . Recent declines in hormone therapy utilisation and breast cancer incidence: clinical and population based evidence. J Clin Oncol 2006;24: e49–50
   PubMed Web of Science ®Google Scholar
• Ravdin P, Cronin KA, Howlader N, . The decrease in breast cancer incidence in 2003 in the United States. N Engl J Med 2007;356:1670–4
   PubMed Web of Science ®Google Scholar
• Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. National Cancer Institute-sponsored Breast Cancer Surveillance Consortium. J Natl Cancer Inst 2007;99:1335–9. Erratum in J Natl Cancer Inst 2007;3;99:1493
   PubMed Web of Science ®Google Scholar
• Sprague BL, Trentham-Dietz A, Remington PL. The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer. Cancer Causes Control 2011;22: 125–34
   PubMed Web of Science ®Google Scholar
• Owen OG. Breast cancer incidence rising in Asian women at younger age: Sunitiniab shows potential as treatment for metastatic disease. Med News Today February 18, 2008
   Google Scholar
• Yip CH. Breast cancer in Asia. Methods Mol Biol 2009;471: 51–64
   PubMedGoogle Scholar
• Chia K-S, Relly M, Tan C-S, . Profound changes in breast cancer may reflect changes into a Westernised lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 2005;11:302–6
   Google Scholar
• Salpeter SR, Walsh ME, Greyber E, Ormiston TM, Salpeter EE. Mortality associated with hormone therapy in younger and older women. J Gen Intern Med 2004;19:791–804
   PubMed Web of Science ®Google Scholar
• Welton AJ, Vickers MR, Kim J, . Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ 2008;337:1190
   PubMed Web of Science ®Google Scholar
• Cumming GP, Currie HD, Panay N, . Stopping hormone replacement therapy: where women ill advised? Menopause Int 2011;17:73–4
   PubMedGoogle Scholar